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treatment (e.g. inpatient vs. outpatient). Some
covered all DSM disorders, while others focused
on only the most prevalent or most costly disorders
to treat, with the goal of cost containment rather
than clinically efficacious care.5
Interviews with administrators
A total of 7 CMHC administrators and 5 MCO
administrators participated in telephone interviews.
Main topic areas addressed in the interviews were
whether clinicians used CPGs, how and when the
organizational decision to use protocols took
place, how use is monitored, and a description of
benefits and disadvantages of CPG use. All but
one MCO and all CMHCs reported requiring that
clinicians use a specific set of CPGs. Results
indicated that MCO administrators reported
CPGs as promoting quality and consistency in
service provision as the primary reason for use,
while CMHC administrators' primary motivation
for use is that it is a requirement imposed by
MCOs for reimbursement or accrediting agencies
for licensing and accreditation.  Noted benefits of
CPGs included shorter treatment, less room for
clinician error, and greater standardization of
treatment. Some respondents noted no disadvan-
tages to CPGs. Noted disadvantages included
negative perceptions of CPGs by clinicians, high-
ly detailed CPGs can be difficult to follow, and
CPGs don't address the range of the clientele they
serve. Training offered to clinicians for use of
CPGs was highly variable, from "clinicians are
always welcome to ask questions, but formal
training isn't offered" to training during orientation
at time of hire, to an unspecified "unified effort to
provide training." 
Focus groups with clinicians
Four focus groups, with a total of 32 therapists,
were conducted.  One group (n=8) were in private
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With the recent focus in mental healthcare on evidence-based and efficacioustreatments, many clinics and managed
care organizations have adopted the use of
clinical practice guidelines (CPGs) to aid in the
treatment of patients with mental health disorders.
CPGs have been defined as "Systematically
developed statements to assist practitioner and
patient decisions about appropriate health care
for specific clinical circumstances."1 They are
patient focused, and they tend to be condition
or treatment specific.  Guidelines are viewed
by policy makers as an important factor in
decision-making about payment practices and
other policy issues, but they can provoke
cont rover s i e s  among  p rov ide r s  and
researchers.2
To address the issues in the implementation
and use of CPGs in clinical settings, a set of
studies was sponsored by the Florida Agency
for Health Care Administration (AHCA) and
undertaken by this author and researchers at
the University of S. Florida.3 First, a review of
the CPGs used by local CMHCs and MCOs
was undertaken. Next, interviews and focus
groups were conducted with administrators
and clinicians to learn more about the process
of adopting and using CPGs in clinical practice.  
Review of Clinical Practice Guidelines
Previous studies have indicated great variation
in the CPGs in use by MCOs,4-5 and our review
was in keeping with these findings. Review of
the CPGs in use at the time indicated tremendous
variation. Some CPGs indicated very specific
treatments in line with current literature on
efficacious treatment for a variety of mental
disorders. At the same time, other CPGs
focused primarily on guidelines for level of
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practice while the rest worked at CMHCs. Among
clinicians, most reported that they were unfamiliar with
CPGs, even when their agencies required their use. Those
who knew of them typically had only seen them during
orientation, exemplified by the comment "I know what
shelf they are on." There was little to no training on CPGs
reported by most participants.  Those who did have more
than passing familiarly with the CPGs used by the
organizations they worked for or with, tended to be
private practitioners. These clinicians sometimes reported
consulting them in their roles as "self-administrators"
when dealing with insurance companies.  A main theme
was that of clinician resentment of the CPGs. Those with
the least familiarly were also the most likely to express
resentment that CPGs call into question their clinical
judgment, training and expertise. Additional themes
included concern that CPGs are related to doing more
"band-aid therapy" (e.g. treating only the surface symptoms
and not the underlying problems), treatment must focus
only on the presenting problem, clinicians can only treat
the very ill since the number of sessions is limited unless
the client has a severe condition, the number of sessions
approved may not match the treatment recommended by the
therapist. There were concerns that "as soon as clients
reach an O.K. stage they are discharged", not allowing for
treatment to reach a stage that would prevent relapse.3
Issues and Implications
There are different viewpoints about CPGs between
administrators and clinicians. Administrators report
requiring use of CPGs primarily for quality and
consistency in clinical services, and because funders
and accreditors require them. Clinicians report using
them to satisfy administrators, not to guide clinical
services.
It is important to examine how much clinicians may
already be doing in routine care that is congruent
with CPGs. We don't really know what differences
compliance may make at the practice level. 
CPGs vary tremendously in breadth, depth, quality
and intended use.
If CPGs are to have meaningful clinical utility, they
should 1) Reflect the current empirical research base,
2) Be updated regularly, 3) Include known efficacious
and effective treatments, 4) Have clearly defined
terminology (e.g. what is meant by "cognitive
therapy"), 5) Account for moderating variables (e.g. 
functional impairment, ethnic background, co-morbidity) 
There are many barriers to the use of CPGs at the
practice level, including: 1) lack of exposure to CPGs,
2) clinician resentment, 3) concern that compliance will
be too difficult, and 4) many CPGs don't reflect the
research base.
Barriers 1, 2 & 3 can be addressed with education and
training in content and clinical utility of CPGs in use.
In agency settings, meetings with both clinical staff
and administrators can address concerns and differences
of opinion. Barrier 4 can be addressed by only utilizing
and drawing from scientifically sound and up to date
protocols. Administrators need to be aware of where
their CPGs are sound, and where they may fall short of
the current knowledge base.
CPGs aren't all-encompassing. There are gaps in time,
resources and training between the randomized
controlled clinical trials which form the knowledge
base for efficacious treatments, and the real world
practice settings of CMHCs and private practices.  
Training and support for clinicians is needed. Research
is needed to assess if CPGs can be successfully
imple-mented in community settings. Funding and
evaluation of the application of efficacious treatments
for children and adolescents in practice settings is
needed. Training is needed for clinicians at CMHCs in
efficacious treatments for clinical issues they 
frequently encounter (such as MST for treatment of
Conduct Disorder) is needed. 
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